Daniel Tarquinio Selected Research

Diazepam (Valium)

1/2022	Safety of Diazepam Nasal Spray in Children and Adolescents With Epilepsy: Results From a Long-Term Phase 3 Safety Study.
10/2021	Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy.
1/2021	Consistent safety and tolerability of Valtoco® (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long-term, open-label, repeat-dose safety study.
1/2021	Lack of observed tolerance to diazepam nasal spray (Valtoco®) after long-term rescue therapy in patients with epilepsy: Interim results from a phase 3, open-label, repeat-dose safety study.
1/2021	Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long-term, open-label safety study.
1/2020	Pharmacokinetics and safety of VALTOCO (NRL-1; diazepam nasal spray) in patients with epilepsy during seizure (ictal/peri-ictal) and nonseizure (interictal) conditions: A phase 1, open-label study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Tarquinio Research Topics

Disease

6	Epilepsy (Aura) 01/2022 - 01/2020
2	Seizures (Absence Seizure) 01/2021 - 01/2020
2	Rett Syndrome (Rett's Disorder) 01/2019 - 01/2016
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022
1	Hypersensitivity (Allergy) 10/2021
1	Rhinitis 10/2021
1	Generalized Epilepsy 01/2020
1	Neurodevelopmental Disorders 01/2019
1	Osteoporosis 01/2016

Drug/Important Bio-Agent (IBA)

6	Nasal SpraysIBA 01/2022 - 01/2020
6	Diazepam (Valium)FDA LinkGeneric 01/2022 - 01/2020
3	BenzodiazepinesIBA 10/2021 - 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Methyl-CpG-Binding Protein 2IBA 01/2019
1	Biological ProductsIBA 01/2019
1	Diphosphonates (Bisphosphonates)IBA 01/2016
1	Vitamin D FDA LinkGeneric 01/2016
1	CalciumIBA 01/2016

Therapy/Procedure

2	Therapeutics 10/2021 - 01/2021
1	Retreatment 01/2022